What's new

RSS
Date Content
31/05/2018 Human medicines European public assessment report (EPAR): Synagis, palivizumab, Respiratory Syncytial Virus Infections, 13/08/1999, 39, Authorised
31/05/2018 Human medicines European public assessment report (EPAR): Silodyx, silodosin, Prostatic Hyperplasia, 29/01/2010, 12, Authorised
31/05/2018 Committee meeting report: Monthly report on application procedures guidelines and related documents for veterinary medicines: April 2018
31/05/2018 Committee for Medicinal Products for Veterinary Use (CVMP): 17-19 April 2018 , European Medicines Agency, London, UK, from 17/04/2018 to 19/04/2018
31/05/2018 Minutes: Minutes of the CHMP meeting 19-22 March 2018
31/05/2018 Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018 , European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018
31/05/2018 Human medicines European public assessment report (EPAR): Eucreas, vildagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2, 14/11/2007, 17, Authorised
30/05/2018 Orphan designation: Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA (also known as patisiran) for the: Treatment of transthyretin-mediated amyloidosis, 06/04/2017, Positive
30/05/2018 Orphan designation: Chimeric 2'-O-(2-methoxyethyl) modified oligonucleotide targeted to huntingtin RNA for the: Treatment of Huntington's disease, 19/03/2015, Positive
30/05/2018 Orphan designation: Recombinant chimeric monoclonal antibody against CD20 for the: Treatment of chronic lymphocytic leukaemia, 26/11/2009, Positive